[HTML][HTML] Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with …
P Igboeli, A El Andaloussi, U Sheikh, H Takala… - Journal of Medical Case …, 2020 - Springer
Background Premature ovarian failure is a relatively common condition that affects 1–3% of
adult women. Premature ovarian failure occurs when there is loss of ovarian function in …
adult women. Premature ovarian failure occurs when there is loss of ovarian function in …
Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with premature …
P Igboeli, A El Andaloussi, U Sheikh… - Journal of medical …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Premature ovarian failure is a relatively common condition that affects 1-3% of
adult women. Premature ovarian failure occurs when there is loss of ovarian function in …
adult women. Premature ovarian failure occurs when there is loss of ovarian function in …
[引用][C] Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with …
P Igboeli, AE Andaloussi, U Sheikh… - Journal of Medical …, 2020 - jglobal.jst.go.jp
Intraovarian injection of autologous human mesenchymal stem cells increases estrogen
production and reduces menopausal symptoms in women with premature ovarian failure …
production and reduces menopausal symptoms in women with premature ovarian failure …
Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with premature …
P Igboeli, A El Andaloussi, U Sheikh… - Journal of Medical …, 2020 - search.proquest.com
Background Premature ovarian failure is a relatively common condition that affects 1–3% of
adult women. Premature ovarian failure occurs when there is loss of ovarian function in …
adult women. Premature ovarian failure occurs when there is loss of ovarian function in …
Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with premature …
P Igboeli, A El Andaloussi, U Sheikh… - Journal of Medical …, 2020 - search.ebscohost.com
Abstract < bold> Background: </bold> Premature ovarian failure is a relatively
common condition that affects 1-3% of adult women. Premature ovarian failure occurs when …
common condition that affects 1-3% of adult women. Premature ovarian failure occurs when …
[HTML][HTML] Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with …
P Igboeli, A El Andaloussi, U Sheikh… - Journal of Medical …, 2020 - ncbi.nlm.nih.gov
Background Premature ovarian failure is a relatively common condition that affects 1–3% of
adult women. Premature ovarian failure occurs when there is loss of ovarian function in …
adult women. Premature ovarian failure occurs when there is loss of ovarian function in …
Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with premature …
P Igboeli, A El Andaloussi, U Sheikh… - Journal of Medical …, 2020 - europepmc.org
Background Premature ovarian failure is a relatively common condition that affects 1-3% of
adult women. Premature ovarian failure occurs when there is loss of ovarian function in …
adult women. Premature ovarian failure occurs when there is loss of ovarian function in …
[HTML][HTML] Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with …
P Igboeli, A El Andaloussi… - Journal of …, 2020 - jmedicalcasereports.biomedcentral …
Premature ovarian failure is a relatively common condition that affects 1–3% of adult women.
Premature ovarian failure occurs when there is loss of ovarian function in women younger …
Premature ovarian failure occurs when there is loss of ovarian function in women younger …
Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with premature …
P Igboeli, A El Andaloussi, U Sheikh… - Journal of Medical …, 2020 - go.gale.com
Background Premature ovarian failure is a relatively common condition that affects 1-3% of
adult women. Premature ovarian failure occurs when there is loss of ovarian function in …
adult women. Premature ovarian failure occurs when there is loss of ovarian function in …
Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with premature …
P Igboeli, A El Andaloussi, U Sheikh… - Journal of Medical …, 2020 - augusta.elsevierpure.com
Background: Premature ovarian failure is a relatively common condition that affects 1-3% of
adult women. Premature ovarian failure occurs when there is loss of ovarian function in …
adult women. Premature ovarian failure occurs when there is loss of ovarian function in …